Introduction
Sprouty was originally identified in Drosophila as a negative regulator of FGF (fibroblast growth factor) signaling during tracheal development (Hacohen et al., 1998) and later was regarded to be a general inhibitor of the growth factor-induced RTK (receptor tyrosine kinase)-dependent Ras/Raf/ERK (extracellular signal-regulated kinase) signaling pathways involved in Drosophila development and organogenesis (Casci et al., 1999; Kramer et al., 1999; Reich et al., 1999) . The functional mode of dSprouty varies depending on the developmental stages. For instance, during the development of the Drosophila eye, dSprouty interferes with the ERK pathway upstream of Ras (Casci et al., 1999) However, during wing and ovary development, it appears to act downstream or at the level of Raf (Reich et al., 1999) .
In mammals, four Sprouty orthologues (Sprouty 1, 2, 3, 4) have been identified (Minowada et al., 1999; Guy et al., 2003) . In addition, three Sprouty-related genes, Spreds were identified (Sprouty-related Ena/VASP homology 1 domain-containing proteins) . Mammalian Sproutys and Spreds inhibit growth factor-induced cellular responses by inhibiting the RTK-dependent ERK signaling pathway (Gross et al., 2001; Impagnatiello et al., 2001; Lee et al., 2001; Sasaki et al., 2001 Sasaki et al., , 2003 Yigzaw et al., 2001; Hanafusa et al., 2002; Yusoff et al., 2002) . Sproutys are considered to be a candidate of anti-oncogenes, as reduced expression of Sproutys has been shown in several cancers Lo et al., 2006) . Spreds bind to Ras and Raf, thereby suppressing activation of Raf. It is clear that Spred1 is involved in the suppression of the Ras-ERK pathway in vivo, as a loss-of-function mutation of SPRED1 gene was found in human NCFC syndrome, which is caused by dysregulation of the RTK/Ras/ERK pathway (Brems et al., 2007) . On the other hand, several mechanisms for the Sprouty-mediated inhibition of the RTK/Ras/ERK pathway have been proposed, including the avoidance of Grb2-Sos recruitment (Gross et al., 2001; Hanafusa et al., 2002) or the inhibition of Raf Sasaki et al., 2003) .
Recently, it has been reported that XtSprouty inhibits FGF-induced, PLCg-mediated Ca 2 þ mobilization and protein kinase C (PKC) signaling with normal ERK activation during the early stages of gastrulation, whereas Xtspred inhibits ERK activation with little effect on Ca 2 þ flux and PKC signaling (Sivak et al., 2005; Wang et al., 2008) . Similarly, Sprouty4 inhibits vascular endothelial growth factor (VEGF)-A-induced PKC-mediated ERK activation, whereas Sprouty4 does not inhibit EGF as well as VEGF-C-mediated ERK activation (Sasaki et al., 2001 (Sasaki et al., , 2003 Taniguchi et al., 2007) . Molecular basis for the suppression of the PKC pathway remains to be solved.
The structure of Sproutys is composed of a highly conserved cysteine-rich region (CR domain) in the Cterminus and a variable N-terminal region (Guy et al., 2003) . Sprouty2 and Sprouty4 mutants, in which tyrosine residues (Y55 for Sprouty2 and Y53 for Sprouty4) in the N-terminal region are replaced by a non-phosphorylatable residue, have been shown to act as a dominant-negative form for the FGF-induced ERK kinase activation. Therefore, the phosphorylation of these N-terminal tyrosine residues seems to be essential for the inhibitory activity of Sproutys on FGF-induced ERK activation (Sasaki et al., 2001; Hanafusa et al., 2002) . However, in the case of VEGF-A signaling, the N-terminal region including Y53 of Sprouty4 is not necessary for suppression, whereas the CR domain is indispensable (Sasaki et al., 2003) . The Sprouty2 CR domain has been shown to bind to phosphatidylinositol 4,5-biphosphate (PIP 2 ), which is not essential for the suppression of ERK activation . Therefore, the suppression mechanisms of Sproutys are diverse depending on the growthfactor receptors.
This study showed that Sprouty4 functions as an inhibitor for PIP 2 hydrolysis induced by VEGF-A, resulting in the suppression of Ca 2 þ mobilization and the various PKC downstream pathways. In addition, Sprouty4 also inhibits lysophosphatidic acid (LPA)-mediated PIP 2 hydrolysis. Therefore, Sprouty4 is a general inhibitor of phospholipase C (PLC), which is activated not only by growth factors but also by GPCR (G-protein-coupled receptor)-activating ligands.
Results

Sprouty4 inhibits the downstream effectors of PKC
It has been shown that Sprouty4 suppressed VEGF-Ainduced ERK activation, whereas Spred1 suppressed not only VEGF-A but also VEGF-C-induced ERK activation . As VEGF-A/ VEGFR-2-mediated ERK activation is dependent on PKC and independent of Ras, Sprouty4 has been proposed to preferentially inhibit the PKC-dependent pathway. However, the detailed mechanism of the Sprouty4 inhibitory effect on the VEGFR-2 signaling pathway has not been clarified.
First, to determine the target of Sprouty4, the downstream effectors of PKC were examined in HEK293T cells stably expressing human VEGFR-2.
Sprouty4 inhibited protein kinase D (PKD, also known as protein kinase Cm) activation, which has been shown to be activated via VEGFR-2/PLCg/PKC (Wong and Jin, 2005; Qin et al., 2006) (Figure 1a ). This suppression was dependent on the C-terminal CR domain but not on the N-terminal region as the C-terminal deletion mutant, Spry4 dC104 did not suppress VEGF-A-induced ERK and PKD activation, whereas the N-terminal deletion mutant, Spry4 dN80 showed an inhibitory effect similar to that of wild Sprouty4. However, Spry4 dN80 did not suppress FGF-A-induced ERK activation ( Figure 1a, right panel) .
Next, the nuclear factor (NF)-kB reporter activation by VEGF-A was examined, as VEGF-A has been shown to activate the IkappaB Kinase (IKK)-NF-kB pathway through PKC (Maeng et al., 2006) . As shown in Figure 1b , VEGF-A enhanced NF-kB reporter activity in HEK293T-VEGFR-2 stable cells, which was inhibited by GF109203X, but not by MEK inhibitor, PD98059 and U0126. Furthermore, dominant-negative form of H-Ras (N17) and Raf-1 (S621A) had little effect on the VEGF-A-NF-kB pathway (data not shown). These findings confirmed that VEGF-A-induced NF-kB activation in 293T cells was dependent on PKC, independent of the Ras/Raf/MEK/ERK pathway. When Sprouty4 was overexpressed, VEGF-A-induced NF-kB reporter activity was suppressed in a dosedependent manner (Figure 1c ). Sprouty4 dC104 lost suppressive effect, whereas Sprouty4 dN80 was unaffected. As is the case with ERK or PKD activity, the C-terminal region of Sprouty4, but not its N-terminal region, was necessary for its suppressive effect on NF-kB activity.
Then, the intracellular translocation of MARCKS, which is a well-characterized PKC substrate was investigated. MARCKS has been known to locate in the plasma membrane without stimulation, whereas translocates to the cytoplasm upon PKC activation. Using green fluorescent protein (GFP)-fused MARCKS (MARCKS-GFP), the translocation of MARCKS can be monitored in living cells by time-lapse confocal laser scanning microscope (Ohmori et al., 2000) . The relative change in the plasma membrane fluorescent intensity was determined in each image using line intensity profiles across the cells (Figure 1d ). Translocation to the cytoplasm was reflected as a relative decrease in fluorescent intensity of plasma membrane and it was calculated by measuring the amplitude of the fluorescent signal at the plasma membrane (I mb ) and dividing it by an average intracellular fluorescent intensity (I cy ) according to the reported procedure (Stauffer et al., 1998) . As shown in Figures 1e and f, MARCKS-GFP rapidly translocated from the plasma membrane to the cytosol in response to the stimulation by VEGF-A, however, it was suppressed by Sprouty4 overexpression. Quantitative data are shown in Figure 1f right panel. The relative change in the fluorescent intensity was significantly decreased in control cells within 60 s after VEGF-A stimulation, whereas it was not observed in Sprouty4 overexpressed cells (Figure 1f) . Again, Sprouty4 dC104 did not suppress MARCKS translocation, Sprouty4 inhibits PIP 2 hydrolysis T Ayada et al whereas Sprouty4 dN80 functioned like the wild Sprouty4 (Figures 1e and f) .
These data indicate that Sprouty4 inhibits the various PKC downstream pathways through the C-terminal CR domain.
Sprouty4 inhibits VEGF-A-induced PKC activation
Next, the effect of Sprouty4 on the activation of PKC was examined. PKC activation was measured by intracellular translocation: PKC activation requires translocation from the cytosol to the plasma membrane. As shown in Figure 2a , VEGF-A-induced translocation of PKCd was inhibited by Sprouty4 overexpression. Sprouty4 dC104 did not inhibit PKCd translocation, whereas an N-terminal deletion still suppressed translocation. These results suggest that Sprouty4 functions at a level upstream of PKC.
Phospholipase Cg catalyzes PIP 2 , resulting in the production of diacylglycerol (DAG) and inositol 1,4,5-triphosphate (IP 3 ): the former activates PKC and the later activates the Ca 2 þ pathway. To clarify whether Sprouty4 inhibits downstream of DAG, PKC activation induced by a membrane-permeable DAG analog, 1,2-dioctonoyl-sn-glycerol (DOG) was assessed. DOGinduced MARCKS and PKCd translocation was not blocked by overexpression of Sprouty4 (Figure 2b ). Furthermore, Sprouty4 did not inhibit DOG-induced ERK activation (data not shown). These data suggest that Sprouty4 inhibits PKC activation at the levels upstream of DAG formation.
Sprouty4 suppresses VEGF-A-induced intracellular Ca 2 þ mobilization Next, the effect of Sprouty4 on the IP 3 -Ca 2 þ pathway, another downstream pathway of PLCg was investigated. First, NF-AT transcription factor activity, which is activated by the Ca 2 þ -calmodulin-calcineurin pathway (Armesilla et al., 1999; Yao and Duh, 2004) was examined. As shown in Figure 3a , VEGF-A-induced NF-AT reporter activation was suppressed by Sprouty4 overexpression. This suppression was again dependent on the C-terminal region but not on the N-terminal region ( Figure 3a) .
Next, to determine whether Sprouty4 suppresses intracellular calcium mobilization, downstream of IP 3 , VEGF-A-induced [Ca 2 þ ] i change was analyzed with an intracellular calcium indicator, Indo-1. Sprouty4-IRES-EGFP cDNA was transiently transfected into 293T-VEGFR-2 cells and then loaded with Indo-1. The cell suspension was stimulated with VEGF-A and the change of [Ca 2 þ ] i in EGFP-positive cells was measured by flow-cytometry. Ca 2 þ mobilization was smoothly induced by VEGF-A in control 293T-VEGFR-2 cells whereas it was strongly suppressed in Sprouty4-overexpressing cells (Figure 3b ). These data indicate that Sprouty4 inhibits VEGF-A-induced Ca 2 þ mobilization.
Sprouty4 suppresses VEGF-A-induced PIP 2 breakdown but not PLCg activation Next the VEGF-A-induced IP 3 production, the upstream of Ca 2 þ mobilization, was examined. Figure 4a shows that VEGF-A stimulation resulted in the accumulation of IP 3 in 293T-VEGFR-2 cells, whereas Sprouty4 overexpression inhibited the accumulation of IP 3 ( Figure 4b ). Sprouty dC104 exhibited no inhibitory activity on VEGF-A-induced IP accumulation, whereas Sprouty dN80 showed a similar inhibition to wild Sprouty4. To confirm the interference of PIP 2 hydrolysis by Sprouty4, the GFP-fused PH domain of PLCd-1 was introduced. GFP-PLCd-1 PH domain selectively binds to both PIP 2 and IP 3 , and PLC activation triggered dissociation of the PH domain of PLCd-1 from the plasma membrane to cytosol, which represents PIP 2 hydrolysis and IP 3 production in the cytosol (Lemmon et al., 1995) . In our study of live cell imaging, VEGF-A induced rapid translocation of GFP-PH domain from plasma membrane to cytosol in 293T-VEGFR-2 cells, whereas Sprouty4 overexpression strongly inhibited mobilization of GFP-PH domain (Figure 4c ).
PLCg plays a major role in PIP 2 hydrolysis in response to RTK-activating ligands including VEGF-A. Mammalian PLCg consists of two isozymes, PLCg-1 and PLCg-2. PLCg-1 shows a ubiquitous expression pattern, whereas expression of PLCg-2 is restricted to B cells or platelets (Ozdener et al., 2002) . As PLCg-1 is a major PLCg isoform in HEK293 cells, we measured VEGF-A-induced PLCg-1 phosphorylation. Overexpression of Sprouty4 did not suppress PLCg-1 phosphorylation; it rather enhanced PLCg-1 phosphorylation (Figure 4d ). Sprouty4 overexpression had no effect on PLCg-1 binding to the VEGFR-2 (data not shown). These data suggest that Sprouty4 inhibits PIP 2 hydrolysis without attenuating PLCg activation, resulting in the suppression of IP 3 and DAG formation; thus, Ca 2 þ mobilization and PKC activation were blocked by Sprouty4 overexpression.
Essential role of the C-terminal PIP 2 binding site of Sprouty4 in VEGF-A signaling Earlier report indicates that R252 of human Sprouty2 is supposed to be a responsible amino residue for PIP 2 binding . CLUSTALW multiple sequence alignment program suggests that R235 of murine Sprouty4 corresponds to R252 of human Sprouty2 (Figure 5a ). To investigate the role of PIP 2 binding domain of Sprouty4, we constructed C-terminal internal deletion mutant vectors, D223-252, which could disrupt PIP 2 binding site. As expected, D223-252 mutant could not co-localize with PIP 2 at the plasma membrane, rather preferentially localized in the nucleus, whereas wild Sprouty4 co-localized with PIP 2 (Figure 5b ). VEGF-A-induced IP 3 production ( Figure 5c ) as well as PKD and ERK phosphorylation ( Figure 5d) were not suppressed by D223-252 overexpression.
Spreds has also been shown to bind to PIP 2 . Therefore, we examined the effect of Spred1 overexpression on VEGF-A-induced PKC activation. In 293T-VEGFR2 cells, Spred1 inhibited VEGF-A-induced MARCKS and PKCd translocation (Figure 5e ), which is inconsistent with an earlier report Sprouty4 inhibits PIP 2 hydrolysis T Ayada et al (Sivak et al., 2005) . Likewise, VEGF-A-induced IP 3 production was suppressed by Spred1 overexpression, but suppression by Spred1 was not as strong as that by Sprouty4 (Figure 5f ). Thus, Spred1 can potentially suppress both of the PLC/PKC pathway and the Ras/ Raf pathway, however, Spred1 is supposed to be more specific to the Ras/Raf pathway when compared with Sprouty4. The HEK293T cells were co-transfected with myc-tagged Sprouty4 and the MARCKS-GFP or PKCd-GFP plasmids. GFP translocation in live cells was triggered by direct application of 1 mM DOG and analyzed by confocal laser scanning microscopy. The ratio of fluorescent intensities ((I mb ÀI cy )/(I mb þ I cy )) was determined as described in Figures 1f and 2a  (n ¼ 5) . The color reproduction of this figure is available on the html full text version of the manuscript.
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Enhanced PIP 2 breakdown in Sprouty4-deficient MEFs To confirm the above hypothesis at physiological Sprouty4-expression levels, Sprouty4-deficient mouse embryonic fibroblasts (MEFs) stably expressing exogenous VEGFR-2 were used. In Sprouty4-deficient MEFs, VEGF-A-induced PKD and MARCKS activation were enhanced and sustained in comparison with the wild-type MEFs, whereas ERK phosphorylation was similar between wild-type and Sprouty4 KO MEFs (Figure 6a ). On the other hand, phosphorylation level of PLCg-1 in Sprouty4-deficient MEFs was slightly lower than that in wild-type MEFs (Figure 6a) . Then VEGF-A-induced IP 3 production was measured (Figure 6b ). Sprouty4-deficient MEFs exhibited higher IP 3 accumulation in response to VEGF-A than wildtype MEFs. These data indicate that Sprouty4 inhibits PLCg-mediated PIP 2 breakdown at physiological expression levels.
Sprouty4 suppresses GPCR-mediated PIP 2 breakdown in MEFs
The data suggest that Sprouty4 inhibits PLCg-mediated PIP 2 hydrolysis, thereby suppressing PKC activation and Ca 2 þ mobilization. As the Sprouty4 CR domain has been shown to bind to PIP 2 , Sprouty4 may inhibit PIP 2 hydrolysis simply by protecting PIP 2 from the access of PLCg. If this is the case, Sprouty4 may inhibit PIP 2 breakdown by stimulations other than growth factors. LPA is a well-characterized ligand that activates the PLCb/e-IP 3 /DAG pathway via the GPCRs) (Kelley et al., 2006) . Therefore, the effect of Sprouty4 on LPA-induced PLC signaling was examined in NIH3T3 cells. LPA-induced Ca 2 þ mobilization was completely suppressed by Sprouty4 overexpression (Figure 7a) . Likewise, Sprouty4 suppressed LPAinduced PKC activation, which was measured by MARCKS translocation (Figure 7b) . Moreover, Sprouty4 overexpression suppressed PIP 2 breakdown Sprouty4 inhibits PIP 2 hydrolysis T Ayada et al measured by GFP-PH domain translocation (Figure 7c ). Lastly, LPA-induced IP 3 production in Sprouty4-deficient MEFs was higher than that in wild-type MEFs (Figure 7d ). These results indicate that Sprouty4 suppresses the PIP 2 hydrolysis induced not only by tyrosine kinase-activated PLCg but also by GPCRactivated PLCb/e.
Discussion
Sprouty negatively modulates branching morphogenesis in the Drosophila tracheal system (Hacohen et al., 1998) . Murine Sproutys have also been implicated in branching morphogenesis. For example, mSprouty1 has been shown to regulate branching of ureteric Sprouty4 inhibits PIP 2 hydrolysis T Ayada et al bud-derived epithelial tubes (Basson et al., 2005 (Basson et al., , 2006 , mSprouty2 regulates embryonic lung branching morphogenesis (Tefft et al., 1999) as well as motor nerve networks in digestive organs (Taketomi et al., 2005) . Angiogenesis is another form of branching morphogenesis and the overexpression of mSprouty4 has been shown to inhibit branching and sprouting of small vessels (Lee et al., 2001) . In vitro, Sprouty4 inhibits VEGF-A-mediated cell proliferation, migration and ERK phosphorylation in endothelial cells. We have found that implanted tumors grow much more rapidly in Sprouty4-deficient mice than in WT mice, due to enhanced neovascularization around and inside the tumor (Taniguchi K, unpublished observation). Thus, 
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we propose that Sprouty4 functions as anti-oncogene by regulating not only ERK activity but also tumor angiogenesis. However, the molecular mechanism of the action of Sprouty4 for VEGF signaling remains to be elucidated. This study found that Sprouty4 negatively regulated PIP 2 breakdown rather than the Ras-mediated ERK activation among the VEGF-A-induced signals. For this suppression, the C-terminal CR domain, but not the N-terminal tyrosine containing region, was essential. This mechanism can explain several inconsistent observations concerning the Sproutys. Sprouty4 inhibits FGF-mediated ERK activation, where the N-terminal tyrosine Y53 plays an essential role. The phosphorylated N-terminal tyrosine residue of Sprouty2 has been shown to interact with Grb2 and inhibits Grb2-SOS complex to the FGF receptor (FGFR) docking adaptor protein FRS2 or to Shp2 (Hanafusa et al., 2002) . However, this tyrosine residue is not required for the suppression of VEGF-A-mediated ERK activation. VEGF-A-induced ERK activation was almost completely dependent on PKC and independent of Ras. This study showed that C-terminal CR domain plays an essential role in PKC suppression, Ca 2 þ mobilization, as well as IP 3 production. In addition, the CR domain interacts with Raf-1, which inhibits Raf-1 activation (Sasaki et al., 2003) . Therefore, the suppression of both PIP 2 breakdown and inhibition of Raf-1 activation by the CR domain seems to be an efficient regulatory mechanism of Sprouty4 for PKC-mediated ERK activation.
Sprouty4 inhibits PIP 2 breakdown downstream of PLCg, as PLCg phosphorylation was not attenuated by Sprouty4 overexpression. As a result, how does Sprouty4 inhibit PIP 2 hydrolysis? It is possible that Sprouty4 directly inhibits the enzyme activity of PLCg. However, we did not observe any physical interaction between PLCg-1 and Sprouty4 (data not shown). Furthermore, it is the fact that Sprouty4 inhibits PIP 2 hydrolysis induced not only by PLCg but also by PLCb/e. Therefore, it is unlikely that Sprouty4 physically inhibits PLC catalytic activity. Lim et al. (2002) reported that Sprouty CR domain interacts with PIP 2 . The plasma membrane localization of Sprouty2 was abolished after PIP 2 was specifically reduced in cells . Therefore, the simplest idea is that binding of the Sprouty4 CR domain to PIP 2 interferes with the access of PLCs to their substrate. In fact, we confirmed that both the inhibitory effect on PKC and the co-localization with PIP 2 were impaired by internal deletion of C-terminal PIP 2 binding site. However, the stoichiometry of PIP 2 and Sprouty4 may not be able to fully explain this model. Sprouty4 may inhibit the recruitment of PLC to a microdomain of the plasma membrane where PIP 2 is concentrated. Further study is necessary to define the precise mechanism for the suppression of PIP 2 hydrolysis by Sprouty4.
Interestingly, Abe and Naski, (2004) reported Sprouty expression to be enhanced by PLCg and calciumdependent signaling. They showed that the induction of Sprouty is inhibited by chelation of intracellular or extracellular calcium and that an FGFR deficient for PLCg signaling only weakly induces Sprouty expression. Therefore, Sprouty4 could be a negative feedback regulator of the PLCg-PKC and/or Ca 2 þ pathway. We found that Sprouty4 overexpression enhanced PLCg-1 phosphorylation, whereas loss of Sprouty4 reduced PLCg-1 phosphorylation. We speculate that phosphorylation of PLCg-1 is negatively regulated by some phosphatases activated downstream of PLC, such as Ca 2 þ , DAG, PKC or ERK. Overexpression of Sprouty4 can prevent such negative feedback circuit.
In our earlier report, we concluded that Sprouty4 has no effect on VEGF-A-induced PKC activation, as Sprouty4 did not affect VEGF-A-induced MARCKS phosphorylation (Sasaki et al., 2003) . We confirmed that phosphorylation of MARCKS was not suppressed by Sprouty4 overexpression in 293T cells. However, we found that this phosphorylation did not correlate with translocation. We observed heavy Ser152/156 phosphorylation of MARCKS in 293T cells before stimulation. PKC inhibitors suppressed MARCKS translocation (data not shown). Therefore, we concluded that MARCKS translocation, but not phosphorylation, is dependent on PKC activation in 293T cells. As Sprouty4 Figure 6 Enhanced PIP 2 breakdown in Sprouty4-deficient MEFs. (a) MEFs stably expressing VEGFR-2 were serum-starved for 18 h and then stimulated with 25 ng/ml VEGF-A. The cell extracts were immunoblotted with the indicated antibodies. (b) IP accumulation assay was performed using VEGFR-2 stable primary MEFs. The cells were stimulated with 25 ng/ml VEGF-A for 45 min and the reaction was terminated by using ice-cold HClO 4 . Each experiment was performed in triplicate. *Po0.05. The representative data of two independent experiments are shown (a, b).
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T Ayada et al inhibited MARCKS translocation in 293T cells, we concluded that Sprouty4 suppressed PKC activation. In contrast, overexpression of Sprouty4 clearly inhibited both MARCKS phosphorylation and translocation in MEFs in response to LPA. Thus, correlation between MARCKS phosphorylation and translocation induced by PKC activation seems to be dependent on cell types, which was why the correlation was not perfectly observed in 293T cells. Similar conclusion has been reported in several groups (Byers et al., 1993; Swierczynski and Blackshear, 1995) . In any case, Sprouty4 inhibited PLC-mediated MARCKS translocation, which is dependent on PKC activation. There seems to be non-overlapping functions of Sprouty and Spred proteins, although they share structural similarities. This and earlier studies showed that Spreds are more specific to VEGF-C/VEGFR-3 and Sproutys are more specific to Figure 7 Sprouty4 suppresses GPCR-mediated PIP 2 breakdown in MEFs. (a) NIH3T3 cells transfected with DsRed-Sprouty4 were serum-starved for 6 h and then incubated with HBSS containing 5 mM Fluo-3/AM for 45 min in dark at 37 1C. After washing the dye from extracellular solution, Fluo-3 fluorescence was excited through an excitation filter (peak at 480 nm) and collected with an emission filter (peak at 535 nm) using confocal laser scanning microscopy. Images were taken every 2 s. The results shown are representative of three independent experiments. (b, c) NIH3T3 cells were seeded onto a glass-bottomed 35-mm dish and co-transfected with MARCKS-GFP (b), PH (PLCd-1)-GFP (c) and DsRed-Sprouty4. Transfected cells were serum-starved for 6 h and GFP translocation was triggered by the direct application of 1 mM LPA. Time-lapse analysis was performed by confocal laser scanning microscopy and the ratio of fluorescent intensities ((I mb ÀI cy )/(I mb þ I cy )) was determined (n ¼ 5). *Po0.05. (d) The IP accumulation assay was performed using primary MEFs. The cells were stimulated with 1 mM LPA for 45 min and the reaction was terminated by using ice-cold HClO 4 . Each experiment was performed in triplicate and the representative data of two independent experiments are shown. *Po0.05.
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VEGF-A/VEGFR-2. This study suggested that expression of Sprouty and Spred genes regulate angiogenesis and lymphangiogenesis, respectively, in mammalian development . This specificity can be explained by the signals utilized mainly by the different type of receptors: the VEGF-A/VEGFR-2 utilizes the PLCg-PKC pathway and the VEGF-C/ VEGFR-3 utilizes the Ras-ERK pathway. This idea is supported by the fact that SPRED1 is responsible for human NCFC syndrome, which is caused by a disorder of the RTK/Ras/ERK pathway, whereas Sproutys cannot inhibit the activated Ras-ERK pathway as efficiently. Similarly, Sprouty and Spred functions were compared for FGF signaling during gastrulation in Xenopus tropicalis (Sivak et al., 2005) . Spred proteins preferentially inhibit the Ras-ERK cascade that directs mesoderm formation, whereas Sprouty proteins block Ca 2 þ and PKCd signals required for morphogenetic movements during gastrulation. In this study we observed that VEGF-A-induced IP 3 production was partially suppressed by Spred1 overexpression (Figure 5f ), however, suppression by Spred1 was not as strong as that by Sprouty4. Thus, we concluded that Spred1 can potentially suppress both the PLC-PKC pathway and the Ras-Raf pathway, however, Spred1 seems to be more specific to the Ras-Raf pathway compared with Sprouty4. Spred and Sprouty may be involved in the choice of a specific signal pathway from multiple pathways elicited from RTKs during development.
This study showed that Sprouty4 inhibits not only RTK-mediated but also GPCR-mediated PIP 2 breakdown. It is a novel finding, but all phenotypes of Sprouty KO mice have been explained by RTK ligands, such as FGF, VEGF-A and GDNF (glial cell linederived neurotrophic factor). However, this study raised the interesting possibility that Sprouty regulates GPCRligand mediated biological processes. It is notable that enteric nerve development is regulated by GDNF and endothelin-3 (Angrist et al., 1996; Hempstead, 2004) . Therefore, the enteric nerve dysplasia phenotype of Sprouty2 KO mice may be partly explained by hypersignaling of ET-3 (Taketomi et al., 2005) . As the physiological role of GPCR ligand-induced PIP 2 hydrolysis has not been well characterized, Sprouty KO mice could be a useful tool for defining this.
Materials and methods
Cell culture HEK293T cells, MCF-7 and MEFs were cultured in DMEM (Dulbecco's modified Eagle's medium) supplemented with 10% fetal bovine serum, penicillin and streptomycin. To generate HEK293T cells stably expressing VEGFR-2, cells were transfected with pcDNA4/TO-VEGFR-2 using FuGENE HD (Roche Molecular Biochemicals, Mannheim, Germany) and cells were selected with 400 mg/ml zeocin (Invitrogen, San Diego, CA, USA). To generate MEFs stably expressing VEGFR-2, MEFs were infected with the retroviruses produced by PLAT-E, packaging cell line, transfected with pMX-VEGFR-2, and then the infected cells were selected with 1 mg/ml puromycin.
Immunoblot analysis
The cells were lysed in lysis buffer (50 mM Tris-HCl (pH 7.4), 50 mM NaF, 0.5% NP-40, 0.1 mM EDTA, 1 mM DTT, 1 mM sodium orthovanadate and a protease inhibitor cocktail (nacalai tesque, Japan)). About 20 mg of proteins were separated by SDS-PAGE (polyacrylamide gel electrophoresis) and transferred to Immobilon-P nylon membranes (Millipore, Bedford, MA, USA). The following primary antibodies were used: phospho-PLCg-1 (pTyr783) rabbit polyclonal (Biosource, CA, USA), phospho-p44/42 MAPK (ERK) (Thr202/ Tyr204) E10 mouse monoclonal, phospho-PKD/PKCm (Ser744/748) rabbit polyclonal and phospho-MARCKS (Ser152/156) rabbit polyclonal (Cell Signaling Technology, Beverly, MA, USA), PLC g-1 rabbit polyclonal, MARCKS goat polyclonal, ERK2 (C-14) rabbit polyclonal, VEGFR2/ KDR (A-3) mouse monoclonal, Myc (9E10) mouse monoclonal (Santa Cruz Biotechnology, Santa Cruz, CA, USA).
Reagents
Human VEGF-A 165 was purchased from Peprotech (Rocky Hill, NJ, USA). 1,2-dioctonoyl-sn-glycerol (DOG: DAG analog) and Oleoyl-L-a-lysophosphatidic acid sodium salt (LPA) were purchased from Sigma (St Louis, MO, USA). GF109203X (PKC inhibitor), PD98059 (MEK inhibitor) and U0126 (MEK inhibitor) were purchased from Calbiochem (San Diego, CA, USA). Indo-1/AM was purchased from Molecular Probes (Eugene, OR, USA). Fluo-3/AM was purchased from DOJINDO (Kumamoto, Japan).
NF-kB luciferase reporter assay
The NF-kB luciferase assay using NF-kB-responsive promoter-luciferase reporter gene, a generous gift from Dr T Fujita (The Tokyo Metropolitan Institute of Medical Science, Japan), has been described (Fujita et al., 1993) . Briefly, 5 Â 10 4 HEK293T cells were seeded onto 24-well plates on the day before transfection. Cells were transfected using Polyethylenimine with each expression vector. The total DNA concentration was kept constant by supplementing empty-vector DNAs. Luciferase activity was determined using the Promega luciferase assay system. The b-galactosidase vector (20 ng) was used for normalizing transfection efficiencies. The values shown are the averages of one representative experiment in which each transfection was performed in triplicate.
Observation of GFP-tagged MARCKS, PKCd translocation
Ligand-induced MARCKS and PKCd translocation was observed as described earlier (Kuriyama et al., 2004) . In brief, VEGFR-2 stably expressing HEK293T cells were seeded onto six-well plates on the day before transfection. Co-transfection of plasmids was performed by the FuGENE HD transfection reagent (Roche Molecular Biochemicals), according to the manufacturer's standard protocol. The plasmids of GFPtagged MARCKS and PKCd were provided by Dr N Saito (Laboratory of Molecular Pharmacology, Biosignal Research Center, Kobe University). At 6 h after transfection, the cells were collected and spread onto a glass-bottomed culture dish (Iwaki, Japan) and cultured for another 18 h before observation. The culture medium was replaced with serum-starved HBSS (Hank's balanced salt solution). Translocation of fusion proteins was triggered by a direct application of VEGF-A into the buffer to obtain the final concentration at 25 ng/ml. The fluorescence of GFP was monitored under a confocal laser scanning fluorescence microscope (model LSM 510 invert, Carl Zeiss, Jena, Germany). GFP-fused protein was monitored at 488 nm argon excitation with a 510-535 nm band pass barrier filter. Images were collected sequentially every 10 s. All Sprouty4 inhibits PIP 2 hydrolysis T Ayada et al experiments were performed at 37 1C. The relative change in the fluorescent intensity of the plasma membrane to that of the cytosol was calculated by ((I mb ÀI cy )/(I mb þ I cy )) where I mb ; the fluorescence signal intensity at the plasma membrane and I cy ; that at the cytoplasm (Stauffer et al., 1998) .
Measurement of calcium mobilization
The intracellular free Ca 2 þ concentration ([Ca 2 þ ] i ) was measured with a Ca 2 þ -sensitive fluorescent dye, Indo-1/AM (Molecular Probes). VEGFR-2 stably expressing HEK293T cells was seeded onto a 10-cm dish 24 h before transfection. Cells were transfected with each expression vector (pIRES2-EGFP) and then were incubated for 24 h. Thereafter, the culture medium was replaced with serum-starved DMEM and the cells were incubated for another 6 h. Cells were collected with the EDTA-free cell dissociation buffer (Sigma) and incubated with serum-free HBSS containing 3 mM Indo-1/AM for 45 min in the dark at 37 1C. Cells were washed three times and 1 Â 10 6 cells were resuspended in 1 ml HBSS. Cells were prewarmed at 37 1C for 15 min before acquiring them for [Ca 2 þ ] i measurement. For each analysis, the cells were acquired for 204 s at a flow rate of 1000-2000 events/s in a BD-LSR FACS machine equipped with UV lasers. In addition, the ratio metric analyses of Ca 2 þ -bound Indo-1 (FL5)/Ca 2 þ -free Indo-1 (FL4) were performed using the CellQuest (BD Biosciences, San Jose, CA, USA) and Flow Jo (Tree Star, San Carlos, CA, USA) software programs.
Live imaging of PIP 2 hydrolysis
To assess the stimuli-induced PIP 2 hydrolysis, we used GFP-tagged PH domain of PLCd-1 (received from Professor T Sasaki, Department of Pathology and Immunology, Akita University School of Medicine), which was established as an in vivo fluorescent indicator for PIP 2 (Lemmon et al., 1995) . Experimental procedures were the same as the observation of GFP-tagged MARCKS and PKC translocation.
Inositol phosphate (IP) accumulation assay
The cells were seeded at 1 Â 10 5 cells/well in a 12-well plate and transfected with pcDNA3/mSpry4 and its deletion mutants on the following day. After 20 h, the culture medium was replaced with serum-starved fresh medium containing 1 mCi/ml myo-[ 3 H]inositol (GE Healthcare Bioscience, Tokyo, Japan), followed by incubation for another 18-24 h. Cells were washed twice and preincubated for 20 min in Dulbecco's modified Eagle's medium containing 0.5% BSA and 10 mM LiCl, followed by stimulation with VEGF-A (25 ng/ml) for 45 min. Stimulation was terminated by replacing the medium with ice-cold 5% HClO 4 and then incubating it on ice for 2 h. The accumulated IP was purified by ion exchange chromatography (AG1-X8 resin; Bio-Rad, Richmond, CA, USA) and eluted with 0.1 M formic acid/1.0 M ammonium formate for IP 3 elution. The radioactivity was measured by scintillation counting (Gaudreau et al., 1998; Fukunaga et al., 2001) .
Abbreviations
GPCR, G-protein-coupled receptor; IP 3 , inositol 1,4,5-triphosphate; LPA, lysophosphatidic acid; PIP 2 , phosphatidyl inositol 4,5-biphosphate; PKC, protein kinase C; PLC, phospholipase C; VEGF, vascular endothelial growth factor.
